Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2000
12/14/2000WO2000075131A1 Substituted pyrazole compounds
12/14/2000WO2000075108A1 Inhibitors of metalloproteinases
12/14/2000WO2000075107A2 Bradykinin receptor antagonists
12/14/2000WO2000074742A1 Devices and compounds for treating arterial restenosis
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074687A1 Antisense modulation of b7 protein expression
12/14/2000WO2000074684A1 Pharmaceutical formulations for treating postmenopausal and perimenopausal women, and their use
12/14/2000WO2000074681A1 Metalloprotease inhibitors
12/14/2000WO2000074666A2 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidaemia and hyperuricaemia
12/14/2000WO2000074665A2 New use of macrolide compounds for inducing chondrogenic differentiation
12/14/2000WO2000074662A2 Arthritis treatment
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000047231A3 Novel antisense inhibition of rad51
12/14/2000WO2000006187A9 Modulation of apoptosis
12/14/2000CA2751187A1 Use of (-)(3-trihalomethylphenoxy)(4-halophenyl)acetic acid and derivatives thereof for treatment of hyperuricemia
12/14/2000CA2383828A1 26 human secreted proteins
12/14/2000CA2376506A1 Neuromedin b and somatostatin receptor agonists
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376018A1 Angiogenic proteins and uses thereof
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000CA2375882A1 Metalloprotease inhibitors
12/14/2000CA2375876A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000CA2375734A1 Benzothiazinone and benzoxazinone compounds
12/14/2000CA2375485A1 Method for multiplying stem cells
12/14/2000CA2374558A1 Phospholipid transfer protein
12/14/2000CA2374460A1 Inhibitors of metalloproteinases
12/13/2000EP1058690A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
12/13/2000EP1058544A1 Inhibition of tnf activity
12/13/2000CN1276793A Methylenebisphosphonic acid derivs.
12/13/2000CN1276785A N-aroylphenylalanine derivs.
12/13/2000CN1276782A 2-aminotetralines, process for their preparation, and pharmaceutical compositions, for prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276721A Use of 6,7-substd. 2-aminotetralines suitable for preparing pharmaceutical composition for therapeutic treatment of inflammatory and/or autoimmune pathologies
12/13/2000CN1276236A Exterior-applied medical liquor
12/13/2000CN1276235A Chinese-medicinal band for therapy
12/13/2000CN1276234A Medicine for treating rheumatism, rheumatoid disease, hyperosteogeny and arthritis, and its preparing process
12/13/2000CN1276223A Bone setting capsule and its preparing process
12/13/2000CN1276218A Secondary dissolving-in method for preparing 'Zhuifeng Zhentong' plaster for alleviating pain
12/13/2000CN1276215A Process for preparing medical liquor for treating osteomyelitis
12/13/2000CN1059335C Oral liquid for enriching blood and clearing numbness
12/13/2000CN1059329C 'Qingsongsan' medicinal liquor or ointment and preparing method thereof
12/13/2000CN1059324C Bones and tendon recovery cream
12/12/2000US6159995 Substituted diaminocarboxylic acids
12/12/2000US6159967 such as 1-(2-((2R)-(3,4-dichlorophenyl)-4-(3,4,5-trimethoxybenzoyl) morpholin-2-yl)ethyl)spiro(benzo(c)thiophene-1-(3H), 4'-piperidine)-(2S)-oxide; respiratory disease such as asthma
12/12/2000US6159964 Vitronectin receptor antagonists
12/12/2000US6159461 Use of c-kit ligand with TNF-α and hematopoietic factors for the expansion or differentiation of hematopoietic cells
12/07/2000WO2000073764A2 Composition and methods for the therapeutic use of an atonal-associated sequence
12/07/2000WO2000073481A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000WO2000073450A2 Cytoskeleton-associated proteins
12/07/2000WO2000073449A1 Dna encoding snorf33 receptor
12/07/2000WO2000073349A1 Dr4 antibodies and uses thereof
12/07/2000WO2000073342A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000WO2000073327A1 Chemokine receptor ccr3 antagonists
12/07/2000WO2000073324A2 Modulation of gene expression in gastrointestinal inflammation
12/07/2000WO2000073313A1 New tricyclic amidine derivatives as inhibitors of nitric oxide synthase
12/07/2000WO2000073296A2 3-heteroarylalkyl substituted gaba analogs
12/07/2000WO2000073295A1 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
12/07/2000WO2000073294A2 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
12/07/2000WO2000073292A1 Biaryl compounds
12/07/2000WO2000073280A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
12/07/2000WO2000073279A1 4-phenyl-pyrimidine derivatives
12/07/2000WO2000072920A1 Substituted biaryl ether compounds
12/07/2000WO2000072881A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000WO2000072876A2 Prevention and treatment of amyloidogenic disease
12/07/2000WO2000072867A2 Substantially oil-free cyclosporin compositions
12/07/2000WO2000072864A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000WO2000072861A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000WO2000072845A1 Il-8 receptor antagonists
12/07/2000WO2000072840A1 Il-8 receptor antagonists
12/07/2000WO2000072823A1 Preparations for the application of anti-inflammatory agents
12/07/2000WO2000072815A1 Indole derivatives
12/07/2000WO2000072801A2 Alpha v integrin receptor antagonists
12/07/2000WO2000072679A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000WO2000045801A3 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
12/07/2000DE19919585A1 Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen Use of Phyllanthus for the treatment of oxidative stress and other symptoms
12/07/2000CA2414094A1 Pharmaceutical preparations of bioactive substances extracted from natural sources
12/07/2000CA2375855A1 Modulation of gene expression in gastrointestinal inflammation
12/07/2000CA2375827A1 A blocking monoclonal antibody to vla-1 and its use for the treatment of inflammatory disorders
12/07/2000CA2375822A1 Substituted biaryl ether compounds
12/07/2000CA2375683A1 Il-8 receptor antagonists
12/07/2000CA2375674A1 Biaryl compounds
12/07/2000CA2375657A1 Conformationally constrained backbone cyclized interleukin-6 antagonists
12/07/2000CA2375106A1 Compositions and methods for the therapeutic use of an atonal-associated sequence for deafness, osteoarthritis, and abnormal cell proliferation
12/07/2000CA2375104A1 Prevention and treatment of amyloidogenic disease
12/07/2000CA2375047A1 Dna encoding snorf33 receptor
12/07/2000CA2374599A1 Dr4 antibodies and uses thereof
12/07/2000CA2374597A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in the tnf-associated disorders
12/07/2000CA2374295A1 Il-8 receptor antagonists
12/07/2000CA2374222A1 Cytoskeleton-associated proteins
12/07/2000CA2374141A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues
12/07/2000CA2374133A1 Structural models for cytoplasmic domains of transmembrane receptors
12/07/2000CA2373937A1 Alpha v integrin receptor antagonists
12/07/2000CA2372249A1 Chemokine receptor ccr3 antagonists
12/07/2000CA2371247A1 Substantially oil-free cyclosporin compositions
12/07/2000CA2371089A1 3-heteroarylalkyl substituted gaba analogs
12/07/2000CA2368192A1 Preparations for the application of antiseptic agents to the interior of the human or animal body
12/06/2000EP1057480A2 Transdermal estrogen agonist-antagonist therapy
12/06/2000EP1056781A1 Treating and diagnosing macrophage-mediated diseases using fc receptor ligands
12/06/2000EP1056768A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
1 ... 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 ... 820